03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
The Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) requires parties to transactions meet...
Read More >
In Skye Mineral Investors LLC v. DXS Capital (U.S.) Limited, et al., the Delaware Court of Chancery ...
Read More >
Pursuant to its update issued March 31, 2020, the Commonwealth has revised the “COVID-19 Essential ...
Read More >
A company providing services to the Colorado marijuana industry recently moved to dismiss an employe...
Read More >
The economic disruption caused by the COVID-19 pandemic has caused certain companies to rethink prev...
Read More >
In Chester County Employees’ Retirement Fund v. KCG Holdings, Inc. et al the Delaware Court of Chan...
Read More >